Stereotaxis (STXS) Debt Ratio (2010 - 2026)

Stereotaxis' (STXS) quarterly Debt Ratio came in at 0.1 in Q1 2026, up 4.06% quarter-over-quarter from 0.09 in Q4 2025.

Analysis

Stereotaxis (STXS) Debt Ratio (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Debt Ratio for 12 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.1 in Q1 2026; TTM through Mar 2026 was 0.1, a N/A change from a year earlier, with the FY2025 full-year figure at 0.09, down 22.38% from the prior year.
Debt Ratio was 0.1 for Q1 2026 at Stereotaxis, up from 0.09 in the prior quarter.
Over five years, Debt Ratio peaked at 0.12 in Q3 2025 and troughed at 0.09 in Q4 2025.
A 3-year average of 0.11 and a median of 0.11 in 2024 frame the typical range for Debt Ratio.
The widest YoY moves for Debt Ratio: up 22.38% in 2025, down 22.38% in 2025.
Over 3 years, Debt Ratio stood at 0.12 in 2024, then declined by 22.38% to 0.09 in 2025, then climbed by 4.06% to 0.1 in 2026.
The last three Debt Ratio figures came in at 0.1 (Q1 2026), 0.09 (Q4 2025), and 0.12 (Q3 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn	0.30
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn	-
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn	0.30
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn	0.31
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	0.04
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn	0.13
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn	-
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn	0.20
10	Stereotaxis	129.55 Mn	114.93 Mn	3.79 Mn	0.10

Historic Data

Download Data